Diane Seimetz
Direktor/Vorstandsmitglied bei HUMACYTE, INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Diane Seimetz
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
HUMACYTE, INC. | Direktor/Vorstandsmitglied | 09.06.2022 | - |
Independent Dir/Board Member | 09.06.2022 | - | |
Children's Advocacy Center of Collin County, Inc.
Children's Advocacy Center of Collin County, Inc. Services to the Health IndustryHealth Services Children's Advocacy Center of Collin County, Inc. is a non-profit organization. which provides safety, healing, and justice for the children who suffered in child abuse. It offers forensic interviews, family advocacy and support services, therapeutic counseling, and community education. The company was founded in 1992 and is headquartered in Plano, TX. | Direktor/Vorstandsmitglied | - | - |
Cumulus Oncology Ltd.
Cumulus Oncology Ltd. Pharmaceuticals: MajorHealth Technology Cumulus Oncology Ltd. develops oncology drugs. The company was founded by Clare Wareing on November 13, 2017 and is headquartered in Edinburgh, the United Kingdom. | Direktor/Vorstandsmitglied | - | - |
MyoPax GmbH
MyoPax GmbH BiotechnologyHealth Technology MyoPax GmbH is a biotech start-up located in Germany and Denmark that focuses on innovative regenerative therapies for muscle disorders. The German company was spun out of the Charité Universitätsmedizin and the Max Delbrück Center in the Helmholtz Association and joined the BioInnovation Institute in Copenhagen with pre-seed funding. MyoPax leverages its proprietary muscle stem cell technology and cutting-edge gene editing technologies to transform the treatment landscape and improve the quality of life for patients affected by muscle disorders. | Direktor/Vorstandsmitglied | 01.01.2022 | - |
Gründer | 01.01.2022 | - |
Karriereverlauf von Diane Seimetz
Ehemalige bekannte Positionen von Diane Seimetz
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Launch Agency LP
Launch Agency LP Advertising/Marketing ServicesCommercial Services Launch Agency LP provides marketing and interactive communications services. The company was founded in 2003 and is headquartered in Carrolton, TX. | Gründer | 01.01.2003 | - |
Corporate Officer/Principal | 12.10.2011 | - |
Ausbildung von Diane Seimetz
Universität des Saarlandes | Undergraduate Degree |
University of Bonn | Graduate Degree |
Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Statistik
International
Deutschland | 5 |
Vereinigte Staaten | 4 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 4 |
Founder | 2 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 4 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
HUMACYTE, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Launch Agency LP
Launch Agency LP Advertising/Marketing ServicesCommercial Services Launch Agency LP provides marketing and interactive communications services. The company was founded in 2003 and is headquartered in Carrolton, TX. | Commercial Services |
Children's Advocacy Center of Collin County, Inc.
Children's Advocacy Center of Collin County, Inc. Services to the Health IndustryHealth Services Children's Advocacy Center of Collin County, Inc. is a non-profit organization. which provides safety, healing, and justice for the children who suffered in child abuse. It offers forensic interviews, family advocacy and support services, therapeutic counseling, and community education. The company was founded in 1992 and is headquartered in Plano, TX. | Health Services |
Cumulus Oncology Ltd.
Cumulus Oncology Ltd. Pharmaceuticals: MajorHealth Technology Cumulus Oncology Ltd. develops oncology drugs. The company was founded by Clare Wareing on November 13, 2017 and is headquartered in Edinburgh, the United Kingdom. | Health Technology |
MyoPax GmbH
MyoPax GmbH BiotechnologyHealth Technology MyoPax GmbH is a biotech start-up located in Germany and Denmark that focuses on innovative regenerative therapies for muscle disorders. The German company was spun out of the Charité Universitätsmedizin and the Max Delbrück Center in the Helmholtz Association and joined the BioInnovation Institute in Copenhagen with pre-seed funding. MyoPax leverages its proprietary muscle stem cell technology and cutting-edge gene editing technologies to transform the treatment landscape and improve the quality of life for patients affected by muscle disorders. | Health Technology |
- Börse
- Insiders
- Diane Seimetz
- Erfahrung